Literature DB >> 24500677

Predictors of smoking lapse in a human laboratory paradigm.

Daniel J O Roche1, Spencer Bujarski, Nathasha R Moallem, Iris Guzman, Jenessa R Shapiro, Lara A Ray.   

Abstract

RATIONALE: During a smoking quit attempt, a single smoking lapse is highly predictive of future relapse. While several risk factors for a smoking lapse have been identified during clinical trials, a laboratory model of lapse was until recently unavailable and, therefore, it is unclear whether these characteristics also convey risk for lapse in a laboratory environment.
OBJECTIVES: The primary study goal was to examine whether real-world risk factors of lapse are also predictive of smoking behavior in a laboratory model of smoking lapse.
METHODS: After overnight abstinence, 77 smokers completed the McKee smoking lapse task, in which they were presented with the choice of smoking or delaying in exchange for monetary reinforcement. Primary outcome measures were the latency to initiate smoking behavior and the number of cigarettes smoked during the lapse. Several baseline measures of smoking behavior, mood, and individual traits were examined as predictive factors.
RESULTS: Craving to relieve the discomfort of withdrawal, withdrawal severity, and tension level were negatively predictive of latency to smoke. In contrast, average number of cigarettes smoked per day, withdrawal severity, level of nicotine dependence, craving for the positive effects of smoking, and craving to relieve the discomfort of withdrawal were positively predictive of number of cigarettes smoked.
CONCLUSIONS: The results suggest that real-world risk factors for smoking lapse are also predictive of smoking behavior in a laboratory model of lapse. Future studies using the McKee lapse task should account for between subject differences in the unique factors that independently predict each outcome measure.

Entities:  

Mesh:

Year:  2014        PMID: 24500677     DOI: 10.1007/s00213-014-3465-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

1.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings.

Authors:  L S Cox; S T Tiffany; A G Christen
Journal:  Nicotine Tob Res       Date:  2001-02       Impact factor: 4.244

Review 2.  Relapse and maintenance issues for smoking cessation.

Authors:  J K Ockene; K M Emmons; R J Mermelstein; K A Perkins; D S Bonollo; C C Voorhees; J F Hollis
Journal:  Health Psychol       Date:  2000-01       Impact factor: 4.267

3.  Smoking withdrawal dynamics in unaided quitters.

Authors:  T M Piasecki; R Niaura; W G Shadel; D Abrams; M Goldstein; M C Fiore; T B Baker
Journal:  J Abnorm Psychol       Date:  2000-02

4.  Smoking cessation among self-quitters.

Authors:  J R Hughes; S B Gulliver; J W Fenwick; W A Valliere; K Cruser; S Pepper; P Shea; L J Solomon; B S Flynn
Journal:  Health Psychol       Date:  1992       Impact factor: 4.267

5.  Developing and validating a human laboratory model to screen medications for smoking cessation.

Authors:  Sherry A McKee; Andrea H Weinberger; Julia Shi; Jeanette Tetrault; Sabrina Coppola
Journal:  Nicotine Tob Res       Date:  2012-04-06       Impact factor: 4.244

6.  A day at a time: predicting smoking lapse from daily urge.

Authors:  S Shiffman; J B Engberg; J A Paty; W G Perz; M Gnys; J D Kassel; M Hickcox
Journal:  J Abnorm Psychol       Date:  1997-02

7.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Authors:  Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

8.  Relapse prevention: introduction and overview of the model.

Authors:  G A Marlatt; W H George
Journal:  Br J Addict       Date:  1984-09

9.  Immediate hedonic response to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy.

Authors:  Saul Shiffman; Stuart G Ferguson; Chad J Gwaltney
Journal:  Psychopharmacology (Berl)       Date:  2005-11-11       Impact factor: 4.530

Review 10.  Developing human laboratory models of smoking lapse behavior for medication screening.

Authors:  Sherry A McKee
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

View more
  15 in total

1.  Life adversity is associated with smoking relapse after a quit attempt.

Authors:  Andrine Lemieux; Leif Olson; Motohiro Nakajima; Lauren Schulberg; Mustafa al'Absi
Journal:  Addict Behav       Date:  2016-04-06       Impact factor: 3.913

2.  Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse.

Authors:  Mustafa al'Absi; Andrine Lemieux; James S Hodges; Sharon Allen
Journal:  Addict Biol       Date:  2018-08-16       Impact factor: 4.280

3.  Smoking Abstinence-Induced Changes in Resting State Functional Connectivity with Ventral Striatum Predict Lapse During a Quit Attempt.

Authors:  Maggie M Sweitzer; Charles F Geier; Merideth A Addicott; Rachel Denlinger; Bethany R Raiff; Jesse Dallery; F Joseph McClernon; Eric C Donny
Journal:  Neuropsychopharmacology       Date:  2016-04-19       Impact factor: 7.853

4.  Multi-method assessment of distress tolerance and smoking-related factors among adult daily smokers.

Authors:  Amanda R Mathew; Bryan W Heckman; Brett Froeliger; Michael E Saladin; Richard A Brown; Brian Hitsman; Matthew J Carpenter
Journal:  Exp Clin Psychopharmacol       Date:  2018-12-27       Impact factor: 3.157

5.  Momentary changes in craving predict smoking lapse behavior: a laboratory study.

Authors:  Courtney A Motschman; Lisa J Germeroth; Stephen T Tiffany
Journal:  Psychopharmacology (Berl)       Date:  2018-04-27       Impact factor: 4.530

6.  Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial.

Authors:  Mary Falcone; Leah Bernardo; E Paul Wileyto; Cheyenne Allenby; Anne Marie Burke; Roy Hamilton; Mario Cristancho; Rebecca L Ashare; James Loughead; Caryn Lerman
Journal:  Drug Alcohol Depend       Date:  2018-11-13       Impact factor: 4.492

7.  Self-control depletion and nicotine deprivation as precipitants of smoking cessation failure: A human laboratory model.

Authors:  Bryan W Heckman; David A MacQueen; Nicole S Marquinez; James MacKillop; Warren K Bickel; Thomas H Brandon
Journal:  J Consult Clin Psychol       Date:  2017-04

8.  Transcranial Direct Current Brain Stimulation Increases Ability to Resist Smoking.

Authors:  Mary Falcone; Leah Bernardo; Rebecca L Ashare; Roy Hamilton; Olufunsho Faseyitan; Sherry A McKee; James Loughead; Caryn Lerman
Journal:  Brain Stimul       Date:  2015-10-23       Impact factor: 8.955

9.  Combination Lorcaserin and Nicotine Patch for Smoking Cessation Without Weight Gain.

Authors:  Jed E Rose; James M Davis
Journal:  Nicotine Tob Res       Date:  2020-08-24       Impact factor: 4.244

10.  Pain characteristics and nicotine deprivation as predictors of performance during a laboratory paradigm of smoking cessation.

Authors:  Jessica M Powers; Lisa R LaRowe; Bryan W Heckman; Joseph W Ditre
Journal:  Psychol Addict Behav       Date:  2019-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.